Amarin | AMRN - Modal Dan Cadangan





Modal Dan Cadangan Perubahan Tanggal
AbbVie USD -3.27B 628M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amarin USD 458.89M 6.03M 2025-09
AstraZeneca USD 48.67B 2.78B 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
DBV Technologies USD 52.85M 33.37M 2025-09
Esperion Therapeutics USD -301.96M 149.4M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 44.75B 2.7B 2025-09